Johnson & Johnson showed strong growth, especially in pharmaceuticals, while its less-mature biotechnology cousins take a beating.

  • untitled
CNNMoney assistant managing editor Paul LaMonica highlights the latest news from Wall Street and what's moving the markets in his daily investing commentary.
@LaMonicaBuzz